These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 20160027

  • 21. Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential.
    Miyake H, Hara I, Gohji K, Yamanaka K, Hara S, Arakawa S, Nakajima M, Kamidono S.
    Clin Cancer Res; 1999 Oct; 5(10):2824-9. PubMed ID: 10537348
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
    Kausch I, Jiang H, Thode B, Doehn C, Krüger S, Jocham D.
    Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
    [Abstract] [Full Text] [Related]

  • 23. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schröder JK, Bardenheuer W, Seeber S, Huebner K, Schütte J, Opalka B.
    Cancer Res; 2000 Jun 01; 60(11):2780-5. PubMed ID: 10850413
    [Abstract] [Full Text] [Related]

  • 24. Knockdown of Ki-67 by small interfering RNA leads to inhibition of proliferation and induction of apoptosis in human renal carcinoma cells.
    Zheng JN, Ma TX, Cao JY, Sun XQ, Chen JC, Li W, Wen RM, Sun YF, Pei DS.
    Life Sci; 2006 Jan 11; 78(7):724-9. PubMed ID: 16111722
    [Abstract] [Full Text] [Related]

  • 25. Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line.
    Fujimoto E, Sato H, Shirai S, Nagashima Y, Fukumoto K, Hagiwara H, Negishi E, Ueno K, Omori Y, Yamasaki H, Hagiwara K, Yano T.
    Oncogene; 2005 May 19; 24(22):3684-90. PubMed ID: 15782139
    [Abstract] [Full Text] [Related]

  • 26. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC.
    J Natl Cancer Inst; 2006 Jun 21; 98(12):825-38. PubMed ID: 16788156
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
    Fujimoto E, Sato H, Nagashima Y, Negishi E, Shirai S, Fukumoto K, Hagiwara H, Hagiwara K, Ueno K, Yano T.
    Life Sci; 2005 Apr 22; 76(23):2711-20. PubMed ID: 15792837
    [Abstract] [Full Text] [Related]

  • 30. In vivo validation of PAX2 as a target for renal cancer therapy.
    Hueber PA, Iglesias D, Chu LL, Eccles M, Goodyer P.
    Cancer Lett; 2008 Jun 28; 265(1):148-55. PubMed ID: 18439754
    [Abstract] [Full Text] [Related]

  • 31. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
    Hu J, Deng X, Bian X, Li G, Tong Y, Li Y, Wang Q, Xin R, He X, Zhou G, Xie P, Li Y, Wang JM, Cao Y.
    Clin Cancer Res; 2005 Jul 01; 11(13):4658-65. PubMed ID: 16000558
    [Abstract] [Full Text] [Related]

  • 32. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
    Ubai T, Azuma H, Kotake Y, Inamoto T, Takahara K, Ito Y, Kiyama S, Sakamoto T, Horie S, Muto S, Takahara S, Otsuki Y, Katsuoka Y.
    Anticancer Res; 2007 Jul 01; 27(1A):75-88. PubMed ID: 17352219
    [Abstract] [Full Text] [Related]

  • 33. [Inhibition of HPV16 E6 oncogene in cervical cancer by RNA interference].
    Niu XY, Peng ZL, Duan WQ, Wang H, Chen YY, Fan YJ, Cheng YF, Qian XL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan 01; 37(1):14-8. PubMed ID: 16468632
    [Abstract] [Full Text] [Related]

  • 34. Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat.
    Patel SK, Ma N, Monks TJ, Lau SS.
    Mol Carcinog; 2003 Nov 01; 38(3):141-54. PubMed ID: 14587099
    [Abstract] [Full Text] [Related]

  • 35. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression.
    Gu B, Ding Q, Xia G, Fang Z.
    Oncol Rep; 2009 Mar 01; 21(3):635-40. PubMed ID: 19212621
    [Abstract] [Full Text] [Related]

  • 36. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
    Matsuyama M, Yoshimura R, Mitsuhashi M, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T.
    Oncol Rep; 2005 Jul 01; 14(1):73-9. PubMed ID: 15944770
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
    Salceda S, Tang T, Kmet M, Munteanu A, Ghosh M, Macina R, Liu W, Pilkington G, Papkoff J.
    Exp Cell Res; 2005 May 15; 306(1):128-41. PubMed ID: 15878339
    [Abstract] [Full Text] [Related]

  • 39. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S, Tang XY, Umemura S, Itoh J, Takekoshi S, Shima M, Usui Y, Nagata Y, Uchida T, Osamura RY, Terachi T.
    Eur Urol; 2009 Feb 15; 55(2):441-9. PubMed ID: 18395325
    [Abstract] [Full Text] [Related]

  • 40. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation.
    Li W, Hardwick MJ, Rosenthal D, Culty M, Papadopoulos V.
    Biochem Pharmacol; 2007 Feb 15; 73(4):491-503. PubMed ID: 17126818
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.